𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Overview of present day treatment of Parkinson's disease

✍ Scribed by M. D. Yahr


Publisher
Springer
Year
1978
Tongue
English
Weight
646 KB
Volume
43
Category
Article
ISSN
1435-1463

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Selegiline ? An overview of its role in
✍ Wessel, K. ;Szelenyi, I. πŸ“‚ Article πŸ“… 1992 πŸ› Springer-Verlag 🌐 English βš– 389 KB

Selegiline (10 mg per day) selectively inhibits monoamine oxidase type B and thus thwarts the metabolism of dopamine by this enzyme. Selegiline has been used in the therapy of Parkinson's disease since 1986. It enhances the efficacy of levodopa, allows a reduction of the levodopa dose, and improves